Technical Analysis for PCRX - Pacira Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade B 42.87 0.07% 0.03
PCRX closed up 0.07 percent on Wednesday, November 13, 2019, on 41 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical PCRX trend table...

Date Alert Name Type % Chg
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Upper Bollinger Band Walk Strength 0.00%
Stochastic Sell Signal Bearish 0.07%
Upper Bollinger Band Walk Strength 0.07%
Inside Day Range Contraction 0.07%
Overbought Stochastic Strength 0.07%
Upper Bollinger Band Touch Strength 0.07%
Slingshot Bullish Bullish Swing Setup -1.47%

Older signals for PCRX ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Pacira Pharmaceuticals, Inc., a specialty pharmaceutical company, develops, commercializes, and manufactures pharmaceutical products for use in hospitals and ambulatory surgery centers worldwide. It develops pharmaceutical products based on its proprietary DepoFoam drug delivery technology. The company markets EXPAREL, a liposome injection of bupivacaine, an amide-type local anesthetic, indicated for administration into the surgical site to produce postsurgical analgesia; and DepoCyt(e), a liposomal formulation of the chemotherapeutic agent cytarabine indicated for the intrathecal treatment of lymphomatous meningitis, a cancer of the immune system. Its product pipeline comprise EXPAREL that has completed Phase II clinical trials for postsurgical analgesia-nerve block administration; DepoNSAID, which is in preclinical trials for the relief of acute pain; and DepoMethotrexate that is in preclinical trials for the treatment of rheumatoid arthritis and oncology, as well as Bupivacaine Liposome Injectable Suspension for veterinary postsurgical analgesia. Pacira Pharmaceuticals, Inc. has a development and commercialization agreement, and related supply agreement with Aratana Therapeutics, Inc. The company was formerly known as Pacira, Inc. and changed its name to Pacira Pharmaceuticals, Inc. in October 2010. Pacira Pharmaceuticals, Inc. was founded in 2006 and is headquartered in Parsippany, New Jersey.
Medicine Health Cancer Pharmaceutical Pain Surgery Pharmaceutical Products Pharmaceutical Industry In China Pharmacology Rheumatoid Arthritis Dosage Forms Piperidines Drug Delivery Technology Bupivacaine Liposome Surgical Site
Is PCRX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 50.3
52 Week Low 34.64
Average Volume 773,153
200-Day Moving Average 40.5095
50-Day Moving Average 38.9998
20-Day Moving Average 40.962
10-Day Moving Average 42.308
Average True Range 1.6277
ADX 17.32
+DI 24.7219
-DI 22.848
Chandelier Exit (Long, 3 ATRs ) 40.2969
Chandelier Exit (Short, 3 ATRs ) 41.2631
Upper Bollinger Band 44.1501
Lower Bollinger Band 37.7739
Percent B (%b) 0.8
BandWidth 15.566134
MACD Line 1.2352
MACD Signal Line 1.031
MACD Histogram 0.2043
Fundamentals Value
Market Cap 1.73 Billion
Num Shares 40.4 Million
EPS -1.72
Price-to-Earnings (P/E) Ratio -24.92
Price-to-Sales 4.67
Price-to-Book 5.03
PEG Ratio -3.43
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 44.07
Resistance 3 (R3) 44.02 43.58 43.87
Resistance 2 (R2) 43.58 43.27 43.60 43.80
Resistance 1 (R1) 43.22 43.08 43.40 43.27 43.74
Pivot Point 42.78 42.78 42.87 42.80 42.78
Support 1 (S1) 42.42 42.47 42.60 42.47 42.00
Support 2 (S2) 41.98 42.28 42.00 41.94
Support 3 (S3) 41.62 41.98 41.87
Support 4 (S4) 41.67